chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a 25 year old female register nurse referring to herself. Concurrent conditions, medical history and allergies were not reported. The patient's historical drug included a measles virus vaccine live (manufacturer unknown) vaccination on an unknown date in 1994. The reporter stated that on 17-FEB-2015, while she was drawing up a M-M-R II (strength, lot number and expiration date were not reported), vaccine to administered to a patient "I drew up the diluent and was pushing the diluent into the powder part of the vaccine and I think there was some pressure (inside the vial with the powder) and I heard a pop and the needle came apart from the hub of the syringe and either just the diluent and some of the vaccine splashed out onto my scrubs". The reporter indicated that it did not get on her skin and did not splash into her face, eyes or mucous membranes. It was unknown if there was any laboratory data. No concomitant therapies were reported. Additional information is not expected, because the reporter did not consent further follow up.
felt sick; he felt like he had the flu for 3 days after he got the second Pfizer vaccine shot.; This is a spontaneous report from a contactable physician (patient). A male patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number was not reported, Expiry date: unknown) via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on unspecified date for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced felt sick, he felt like he had the flu for 3 days after he got the second pfizer vaccine shot. The outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
a blook clot; blockage in the Left Anterior Descending artery; symptoms of shortness of breath; This is a spontaneous report from a non-contactable consumer or other non hcp.   A 58-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 25Feb2021 17:30 (at the age of 57-years-old) as 2nd dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 on 02Feb2021and experienced cardiac blockage. The patient did not take any other vaccines within 4 weeks prior to the COVID vaccine. On 15Apr2021 the patient experienced a blook clot, blockage in the left anterior descending artery and symptoms of shortness of breath. The events were reported as serious (life threatening). It was reported that 15Apr2021, emergency trip to ER, blockage in the Left Anterior Descending artery.  This blockage was only 40% blocked in Feb2021, and suddenly in April became 99% blocked. Dr suspected a blook clot when symptoms of shortness of breath appeared suddenly. The events resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Blockage in the Left Anterior Descending artery was treated with cardiac stents. The patient underwent lab tests and procedures which included COVID-19 test tested performed on an unspecified date (result not reported). The outcome of events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021600543 same patient, different vaccine dose/events
102 fever, muscle pain, joint pain, bone pain. Felt like very bad flu for 3 days
On unspecified dates, the child received his 1st, 2nd and 3rd injections of Engerix-B (lot ENG2230A2 and Eng2292A2). He also received Infanrix (lot DTPA817A2), DTAP/DTP and Hib-Titer. The child's attorney alleged that "The highly toxic emissions of certain power production facilities in the environmental zone of the Plaintiff's residence contributed to the Plaintiff's total dose of poisonous mercury...Because of Plaintiff's heightened vulnerability to heavy metals poisoning and his compromised condition related to mercury poisoning discussed above, he was and is unable to process heavy metals and suffers neurological compromise as a result of the heavy metals contributed by the fossil-fuel burning utilities. His impaired condition is compounded by these exposures and his injury is made worse by them...The Plaintiff was poisoned by the cumulative doses of mercury in the environment and, as a result, the Plaintiff now suffers, and in the future will continue to suffer from the toxic neurological effects of mercury poisoning". The attorney further alleged that "After being injected with Thimerosal and inhaling mercury-contained emissions...(he) had the following symptoms: severe learning disabilities, impairments in social relatedness, language and communication difficulties, abnormal movements, sensory dysfunction, depressions, anxiety, hearing loss, severe bowel dysfunction and other severe health disorders. (His) problems are caused by Thimerosal and the mercury and/or other heavy metal contained therein". The "severe" learning disabilities, impairments in social relatedness, language difficulties, communication difficulties and mercury poisoning in this report are considered "Medically Serious".
Patient received intranasal live flu vaccine on 12/3/14. On 12/5/14 or there about began having seizure like activity which has grown progressively worse.
Within 10 minutes of the jab, I started to have an asthma attack.  The attack did not resolve until I used my rescue inhaler.
two kidney cysts exactly the same size, one on each kidneys; an adenoma on my rt adrenal gland; This spontaneous case was reported by a consumer and describes the occurrence of RENAL CYST (two kidney cysts exactly the same size, one on each kidneys) and ADRENAL ADENOMA (an adenoma on my rt adrenal gland) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RENAL CYST (two kidney cysts exactly the same size, one on each kidneys) and ADRENAL ADENOMA (an adenoma on my rt adrenal gland). At the time of the report, RENAL CYST (two kidney cysts exactly the same size, one on each kidneys) and ADRENAL ADENOMA (an adenoma on my rt adrenal gland) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: abnormal (abnormal) CT and MRI showed two kidney cysts exactly the same size, one on each kidneys and an adenoma on the right adrenal gland.. On an unknown date, Magnetic resonance imaging: abnormal (abnormal) CT and MRI showed two kidney cysts exactly the same size, one on each kidneys and an adenoma on the right adrenal gland..         No concomitant medication and treatment information was reported.
This is a spontaneous report from a contactable consumer via a Pfizer sales representative reported for herself. A female patient of unknown age received PREVNAR 13 for immunization at 0.5ml single dose via an unspecified route of administration in the arm on unknown date in 2016. Medical history included ongoing asthma. Concomitant medication were not reported. On unknown date at the end of 2016 the patient experienced redness, swelling, itching, pain in the arm the product was administered and pain that radiated into her shoulder. The patient recovered completely from these events a week later. These events lasted for one week.
Pt called her pharmacy 8/12/18 to inform us she was experiencing flu like symptoms starting the day after the SHINGRIX vaccination. Pt also complains of swelling and redness in the left arm (injection site reaction).
I had an allergic anaphylaxis reaction, it happened at 3pm after the 30min wait. I went to lunch with my wife at a place we frequent and started feeling ill. By the time we went to the parking lot I was having trouble breathing and a rash was spreading along my chest. I went back to the convenient MD and they gave me Benadryl and started an IV line and called the ambulance. I was taken to the hospital and stayed 3 days until they could get the allergic reaction under control.
Patient develop a welt immediately after receiving the vaccine. The swelling of the welt decreased in about 15 minutes.
Pt recvd 1st dose of vax & 1-2 hrs post inject exp red, swollen arm, & low grade temp (local react); treated w/DPH in ER;
This is in follow-up to report(s) previously submitted on 2/13/2007. Information has been received from a 52 year old female licensed practical nurse with a penicillin allergy and no other medical history who on 27-NOV-2006 at 10:00 am was vaccinated SC in the left deltoid with a 0.5 mL dose of ZOSTAVAX (Merck) (lot # 652925/0621F). There was no concomitant medication. There was no illness at the time of vaccination. Since November 2006, she has had two incidents or oral herpes simplex lesions. On 16-JAN-2007, she also developed a single vesicular lesion on her forehead that is starting to crust over. No other symptoms were noted. Unspecified medical attention was sought. No diagnostic laboratory tests were performed. At the time of the report, the patient was recovering. A product quality complaint was not involved. Additional information has been requested. Follow-up information from the licensed practical nurse indicated that on 03-DEC-2006 at 7:00 am the patient developed her first herpes simplex on the lip. The patient developed 3 cold sores" on the lip, on canker sore in the mouth, one sore in the nostril, and a blister like lesion on her forehead all within a two month period. It was reported that the patient had no prior problems before ZOSTAVAX (Merck) (lot # 652925/0621F). It was reported that the patient required a doctor visit. She recovered on 30-JAN-2007. Additional information is not expected.
immed following MMR inject pt fell to floor, eyes rolled back ? seizure activity occurred which lasted 30-40 sec; color very pale; no cyanosis; no head injury; BP 100/78, R 20, AP 88; paramedics called immed; MD notified of incident;
On 04/25/2022 Occupational Health Nurse (OHN) contacted employee after receiving report from House supervisor that employee was asking him about a reaction after receiving his Covid vaccine.  OHN called employee,  he states he rec'd his booster dose (dose #3) of Pfizer Covid vaccine on Thursday, 04/21/2022, and on 04/23/2022, he noticed his left arm was red and swollen at injection site, denies pain.  OHN assured employee that swelling and redness can occur.  He has rec'd all 3 vaccines in the same arm.  Per the CDC website, it states that redness, and swelling are common side effects. He states it is getting better.  Advised taking Motrin/Tylenol, cool compresses, and drinking plenty of water.  If it does not improve by the end of the week, to contact OHN and we will have evaluated by Infection Control physician. Understanding verbalized.  I also recommended he go to V-Safe and report side effects for CDC monitoring and data collection.   On 11/22/2022, employee stopped by OHN's office asking whether he should get bivalent vaccine after having previous reaction.  After looking back on documentation.  OHN informed employee that redness and swelling at site would not be a reason to not get vaccine.  He further informed me that he later had swelling under his left axilla.   Describing as softball size swelling and redness.  He states it was not painful, and it returned to normal after 2-3 days.   He did not follow-up with OHN or his PCP at the time.  OHN never visually saw swelling.  OHN recommended he contact his PCP for further guidance as to whether he should receive the Bivalent booster or not.  OHN is documenting softball size adverse reaction now, due to just being made aware.
ran fever following day flushed red splotchy rash under skin on arms-since inj; has felt lethargic; feels tired;
This spontaneous report has been received from a nurse and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB lot # N006321, expiration date 08-NOV-2019 and lot # N009802, expiration date 19-DEC-2019 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 0.8 degrees Celsius for 52 minutes and 10.9 degrees Celsius for 3 hours and 17 minutes. Digital data logger was involved. There were no previous excursions reported. No product quality complaint has been filled. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1709USA007138: US-009507513-1709USA007139: US-009507513-1709USA004848:
Viral disease characterized by exanthema. Lesions look c/w varicella despite the fact that child was immunized. Other viral exanthems on ddx include coxsackie, however pt recently. Recovered from suspected hand/foot/mouth and these lesions do not appear on palms or soles.   Disease characterized by exanthema. Was seen in clinic seven months after Varicella Vaccine for a rash on back and spread to trunk some popular and vesicular lesion in nature. Patient was itching. No confirmed diagnosis of Varicella but rash similar.
pt recv vax 30APR96&during a school clinic 1MAY96 mom states pt woke up&exp orbital edema&facial edema,red rash noted behind ears,on neck&lt hand pinkie area;no diff swallowing,breathing or eating;seen by MD told not vax related
22 hrs of inconsolable crying starting 1 hrs p/inject; local 1" swelling 2" redness;
Bivalent shot given on 9/27/2022. Suffered TIA on 10/14/2022 with Vision blurred and distorted, dizzy, confused, short term memory loss. Seen at Hospital the night of 10/14/2022 for Stroke protocol. EEG, MR without contrast. Seen by Dr on 11/21/2022 with slight light headed and short term memory loss. Vision appears to have returned to normal. MRI, EEG, Labs performed and reviewed by Dr. MRI impression: Moderate to severe chronic microvascular ischemic disease with small chronic infarct in the left thalamus. No preferential hippocampal volume loss. Symptoms of short term memory loss persists.
half of my face paralyzed; My eyes felt like opened more than normal; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of FACIAL PARALYSIS (half of my face paralyzed) and OCULAR DISCOMFORT (My eyes felt like opened more than normal) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. UNK and 037B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 15-May-2021, the patient experienced FACIAL PARALYSIS (half of my face paralyzed) and OCULAR DISCOMFORT (My eyes felt like opened more than normal). At the time of the report, FACIAL PARALYSIS (half of my face paralyzed) and OCULAR DISCOMFORT (My eyes felt like opened more than normal) outcome was unknown.            Concomitant product use was not provided by the reporter. The patient refers to be taking injections [sic] as treatment.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pain at injection site, rash (about 2 by 4 inches) just below site, with headache like pain in layers below skin and itching, intense at times.  Has been constant for 3 days now.
CHILLS; HEADACHE; JOINT ACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 to Left Deltoid for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 08-MAR-2021, the subject experienced headache. On 08-MAR-2021, the subject experienced joint ache. On 09-MAR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from joint ache, and chills on 09-MAR-2021, and had not recovered from headache. This report was non-serious.
19 days p/vax pt exp mild varicella w/less than 50 lesions disseminated on trunk & face
There was no adverse reaction the Hep b was given in error and I was instructed by management to report this to VAERS.
Feeling exhausted; Still did not feel good; Lost range of motion in right arm; Shaking; Restless; Could not stop chilling; Achy all over; Fever; Injection hurt more than any other IM injection including but not limited to the influenza vaccine; had a terrible headache following vaccination; This spontaneous report was received from a nurse concerning a 61 year old female patient who experienced achy all over (pain),  lost range of motion in right arm (joint range of motion decreased),  shaking (tremor), still did not feel good (malaise),  had a terrible headache following vaccination (headache), could not stop chilling (chills), fever (pyrexia), injection hurt more than any other IM injection including but not limited to the influenza vaccine (injection site pain), restless (restlessness) and feeling exhausted (fatigue).  The patient's medical history included COVID 19. Concomitant medications were not reported.   On 03 JAN 2021, prior to the onset of the events, the patient received her first of two planned doses of mRNA-1273 (Lot 039K20-2A) intramuscularly in the right deltoid.  On 03 Jan 2021, the patient experienced injection hurt more than any other IM injection including but not limited to the influenza vaccine, a diminished range of motion in her right arm, which got worse through the night. Within two hours, after vaccination, she began to feel achy all over. She was chilling and shaking and stated that her pain level increased from one to seven and she was restless with the pain overnight. Her temperature went up to 102 degrees F, and day after receiving vaccine she used Tylenol which brought it down to 100, but she still did not feel good. All symptoms that she attributes to the vaccine started fast and she felt like she actually had COVID 19. She had terrible headache, following vaccination, and chills. When she was diagnosed with  COVID, could not taste or smell, and her sense of smell and taste is still touch and go, but she does not believe it was related to the vaccine. Symptoms are no longer ongoing.  Treatment for the events included Tylenol.   Action taken with  mRNA-1273 in response to the events was not applicable. Second dose was scheduled for 29 JAN 2021.   The events of achy all over (pain),  lost range of motion in right arm (joint range of motion decreased),  shaking (tremor), still did not feel good (malaise), had a terrible headache following vaccination (headache), could not stop chilling (chills), fever (pyrexia), injection hurt more than any other IM injection including but not limited to the influenza vaccine (injection site pain), restless (restlessness) and feeling exhausted (fatigue) were considered recovered.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Shot in left arm.  Began feeling tingling in arm (shoulder blades down to fingertips) like arm going to sleep.  Comes and goes.  Still experiencing this intermittently now.  Within a week after shot, also feeling slightly numb at times on left side of face around cheek/jaw line.
Moderna COVID19 EUA   A couple hours or so later headache/migraine lasting the night.   Night waking
Patient experience tension and tightness on right upper shoulder / right neck area.  Patient received vaccine in the right arm.  At 4:40pm, BP 171/93  HR 62  O2=95%.  Symptoms are stable.  Not worsening.  At 4:49pm, BP  153/95  HR 61  O2=95%.  Patient clinically stable.  Patient still has tension on right shoulder/neck.  Patient released from clinic at 4:53pm.
Patient called and left voicemail on 8/26/21 stating she was experiencing an unusual reaction to her flu shot that she received on 8/24/21. The pharmacist on duty called the patient back and went over what was happening. The patient stated that the night she received her vaccine, "a purple waterfilled raised area" appeared on the arm her vaccination was administered on. This was not at the site of the immunization but further down on her arm. Her arm became swollen and red to the touch. She did not seem to think she had a fever but stated she did not feel well. The purple raised area turned white today. The patient stated she has mycosis fungoid. The pharmacist advised her to go to urgent care sooner than later and follow up with her dermatologist.
Two days post vax, pt developed chickenpox with fever and rash.  The pt recovered.
the week following the vaccine a non itchy pinkish rash started on lower abdomen. Over the past 4 wks has spread to legs/arms/stomach.
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication The patient was inoculated with ZOSTAVAX (lot number, dosage, and route of administration not provided) on or about 16-AUG-2012, administered by a physician, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingle as intended, but rather caused the patient to contract a persistent and chronic strain of herpes zoster. On or about 01-AUG-2016, the patient  was treated by the physician for blistering vesicular lesions accompanied by weakened immune symptoms and severe discomfort and distress, which was diagnosed as herpes zoster. The patient  has been prescribed valacyclovir (VALTREX) for management of her painful symptoms and outbreaks. As a direct and proximate result of these malfunctions, the patient has  suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient  has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
vomited 5x w/in 15-20mins post vax, became limp, eyes rolled back;
Sore first two days to be expected, but since then, the soreness has gone away, but, my arm constantly hurts, deep down, it also feels numb like it wants to fall asleep.